Optimizing Acute Ischemic Stroke Diagnostics Using Artificial Intelligence

Launched by OSLO UNIVERSITY HOSPITAL · Dec 7, 2022

Keywords

ClinConnect Summary

This clinical trial, titled "Optimizing Acute Ischemic Stroke Diagnostics Using Artificial Intelligence," is investigating how the latest technology can improve the way doctors diagnose and treat patients who have had a stroke. The goal is to streamline the imaging process, which means using advanced computer techniques to quickly and accurately assess the condition of the brain. This study is currently recruiting participants aged 65 and older who have experienced an ischemic stroke, which is a type of stroke caused by a blockage in the blood vessels supplying the brain.

To participate, individuals must provide informed consent, meaning they agree to take part in the study after being informed about its purpose and procedures. Participants can expect to receive standard care for their stroke, with the added benefit of being part of a cutting-edge research effort that aims to improve stroke treatment for everyone. It's important to note that those who are unable to provide consent or are not available for follow-up assessments will not be included in the study. Overall, this trial is an exciting opportunity to help shape the future of stroke care using innovative technology.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with ischemic stroke.
• • All stroke severities and vascular distributions are eligible.
• • Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines.
• Exclusion Criteria:
• • • Patients not available for follow-up assessments (e.g. non-resident).